Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

Bacterial ghosts (BGs) represent an innovative platform that exploits empty Gram‐negative bacterial envelopes produced through controlled lysis. These envelopes retain the native antigenic ...

The field of antivirals and vaccines is pivotal to modern biomedical research, especially in the context of persistent and emerging viral threats. Recent ...

Recombinant protein vaccines, which are obtained by conventional genetic engineering, are based on the proteins of target pathogens that can activate our immune systems. Unlike other types of vaccines ...

Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...

The content on this page is provided for reference purposes only. This content has not been altered or updated since 22 December 2022 The development and distribution of an effective and safe vaccine ...

The Food and Drug Administration’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory processes. The first sign of trouble was the ...

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...